Context Therapeutics Inc. SEC filings CNTX

Context Therapeutics Inc. has 307 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Context Therapeutics Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
4 Insider transaction Feb 23, 2026 Feb 19, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jun 12, 2025 Jun 12, 2025
4 Insider transaction Jun 12, 2025 Jun 12, 2025
4 Insider transaction Jun 12, 2025 Jun 12, 2025
4 Insider transaction Jun 12, 2025 Jun 12, 2025
4 Insider transaction Jun 12, 2025 Jun 12, 2025
4 Insider transaction Jun 12, 2025 Jun 12, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 9, 2025 Jun 9, 2025
3 Initial insider ownership Jun 9, 2025 Jun 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 14, 2025 Feb 13, 2025
4 Insider transaction Feb 14, 2025 Feb 13, 2025
4 Insider transaction Feb 14, 2025 Feb 13, 2025
4 Insider transaction Feb 14, 2025 Feb 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 27, 2025 —
4 Insider transaction Jan 14, 2025 Jan 13, 2025
3 Initial insider ownership Jan 14, 2025 Jan 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 8, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
4 Insider transaction Sep 5, 2024 Sep 4, 2024
3 Initial insider ownership Sep 5, 2024 Sep 4, 2024
4 Insider transaction Sep 5, 2024 Sep 4, 2024
3 Initial insider ownership Sep 5, 2024 Sep 4, 2024
4 Insider transaction Aug 1, 2024 Aug 1, 2024
3 Initial insider ownership Aug 1, 2024 Aug 1, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
SC 13G Ownership over 5% (passive) Jun 5, 2024 —
SC 13G Ownership over 5% (passive) May 24, 2024 —
SC 13G Ownership over 5% (passive) May 13, 2024 —
SC 13G Ownership over 5% (passive) May 10, 2024 —
4 Insider transaction Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
4 Insider transaction Mar 22, 2024 Mar 21, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
SC 13G Ownership over 5% (passive) Jan 5, 2024 —
4 Insider transaction May 31, 2023 May 31, 2023
4 Insider transaction May 31, 2023 May 31, 2023
4 Insider transaction May 31, 2023 May 31, 2023
4 Insider transaction May 31, 2023 May 31, 2023
4 Insider transaction Feb 21, 2023 Feb 21, 2023
4 Insider transaction Feb 14, 2023 Feb 13, 2023
4 Insider transaction Feb 14, 2023 Feb 13, 2023
4 Insider transaction Feb 14, 2023 Feb 13, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
4 Insider transaction Feb 13, 2023 Feb 13, 2023
4 Insider transaction Feb 6, 2023 Feb 6, 2023
4 Insider transaction Jan 30, 2023 Jan 30, 2023
4 Insider transaction Jan 23, 2023 Jan 23, 2023
4 Insider transaction Jan 18, 2023 Jan 17, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 9, 2023 —
4 Insider transaction Dec 19, 2022 Dec 16, 2022
4 Insider transaction Dec 19, 2022 Dec 16, 2022
4 Insider transaction Dec 12, 2022 Dec 9, 2022
SC 13G Ownership over 5% (passive) Oct 27, 2022 —
4 Insider transaction Aug 22, 2022 Aug 19, 2022
4 Insider transaction Aug 17, 2022 Aug 17, 2022
4 Insider transaction Aug 17, 2022 Aug 16, 2022
4 Insider transaction Aug 12, 2022 Aug 12, 2022
4 Insider transaction Jun 3, 2022 Jun 2, 2022
4 Insider transaction Jun 3, 2022 Jun 2, 2022
4 Insider transaction Jun 3, 2022 Jun 2, 2022
4 Insider transaction Jun 3, 2022 Jun 2, 2022
SC 13G Ownership over 5% (passive) May 9, 2022 —
4 Insider transaction Feb 25, 2022 Feb 25, 2022
4 Insider transaction Feb 25, 2022 Feb 25, 2022
4 Insider transaction Feb 25, 2022 Feb 25, 2022
4 Insider transaction Feb 17, 2022 Feb 15, 2022
4 Insider transaction Feb 17, 2022 Feb 15, 2022
SC 13G Ownership over 5% (passive) Feb 2, 2022 —
SC 13G/A Amended ownership over 5% (passive) Jan 5, 2022 —
4 Insider transaction Dec 20, 2021 Dec 16, 2021
4/A Form 4/a Dec 17, 2021 Oct 22, 2021
4/A Form 4/a Dec 17, 2021 Oct 22, 2021
3/A Form 3/a Dec 17, 2021 Oct 19, 2021
3/A Form 3/a Dec 17, 2021 Oct 19, 2021
SC 13G Ownership over 5% (passive) Dec 6, 2021 —
4 Insider transaction Nov 1, 2021 Nov 1, 2021
3 Initial insider ownership Nov 1, 2021 Nov 1, 2021
4 Insider transaction Oct 25, 2021 Oct 22, 2021
4 Insider transaction Oct 25, 2021 Oct 22, 2021
4 Insider transaction Oct 25, 2021 Oct 22, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021
3 Initial insider ownership Oct 19, 2021 Oct 19, 2021

Showing 133 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CNTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Philadelphia, PA
SEC filer status
, Emerging growth company
SEC CIK
1842952
Former names
Context Therapeutics LLC (until May 3, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.